Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation

Although patients with locally advanced pancreatic cancer (LAPC) have an extremely poor prognosis, they are a heterogeneous group. Prognostic factors are inadequately defined for disease-free survival and overall survival in patients with LAPC who are receiving chemoradiation, so more definitive prognostic factors would be very useful for designing clinical trials.Between December 1993 and July 2005, 247 patients with nonmetastatic LAPC were...